Introduction. Colorectal liver metastases have a poor prognosis and only 2% have an average 5-year survival if left untreated. In recent decades there has been a development in the diagnosis, treatment and palliative treatment of patients with colorectal liver metastases, and despite radical resection the average five-year survival is between 25% and 44%. Aim. To explore the experience of the Clinic in the treatment of colorectal liver metastases, comparing it with data from the literature and based on the comparison to determine the prognostic factors that affect survival after radical surgical treatment of patients. Methods. A retrospective study was conducted at the Clinic of General and Hepato-pancreatic Surgery at the University Hospital "Aleksandrovska"-Sofia. The study comprised the period between 01.01.2006 to 31.12.2015. It included a total of 239 cases, of whom: 179 patients underwent radical interventions, 5 palliative and 55 patients underwent explorative interventions due to liver metastases. Clinical and pathological materials were analyzed using SPSS-19 to determine the prognostic significance of a number of factors in relation to the survival: gender, age, type and localization of metastases, postoperative stage of the primary tumor, type and volume of liver resection, extrahepatic metastases, preoperative values of CEA, postoperative values (AST, ALT). Results. Factors that correlated with lower survival type: metastases (synchronous or metachronus), localization of metastases (uni-or bilobar), presence of the regional lymph node metastases and metastases to other distant organs and the impossibility of radical resection of liver were statistically significant with multivariant analysis. Elevated preoperative value of CEA, the value of hemoglobin and stage IV disease also affected the survival of patients. Conclusion. In patients with colorectal liver metastases only resection has potentially curative character. The
Introduction
Colorectal cancer CRC is the third most common cancer worldwide after lung cancer and breast cancer [1, 2] . A large percentage of 50-70% of patients develops colorectal liver metastases (CRLM) because of hematogenous dissemination of primary cancer [3] [4] [5] [6] [7] . Synchronous metastases are diagnosed in 15-25% [8] [9] [10] during the primary diagnosis of CRC and in 20-25% [11] [12] [13] [14] [15] in the first five years metachronous metastases develop. They represent the most common cause of death caused, so that 77% of untreated patients die in the first year, and only 14-23% survive more than three years [16] [17] [18] [19] . Surgical resection represents the only curative treatment approach to patients with CRLM; in larger series patients treated with resection have a mean 5-year survival from 25% to 44% [15, 20, 21] , but only 15-25% [22] of metastasis of liver are initially resectable. Poor prognosis of the disease is the cause of looking for opportunities to improve postoperative results which corresponds with defining determinants of survival. Aim. To explore the experience of the Clinic in the treatment of colorectal liver metastases, comparing them with data from the literature, and based on the comparison to determine the prognostic factors that affect survival after radical surgical treatment of patients.
Methods and materials
A retrospective study was conducted at the Clinic of General and Hepato-pancreatic surgery at the University Hospital "Aleksandrovska"-Sofia. The follow-up period of the patients operated on for colorectal liver metastases in the Clinic, was 5 years after resection of the liver according to the method of Kaplan-Mayer. Statistical analysis of the collected material to determine the factors for survival was done using SPSS-19, and it included sex, age, type and localization of metastases, postoperative stage of primary tumor, type and amount of resection of the liver, extrahepatic metastases, preoperative CEA values and postoperative values (AST, ALT).
Results
The cumulative overall survival is shown in Table 2 , and it was 79.6% in the first year, 25.9% in the third year, and 19.2% in the fifth year. The analysis by age showed that the median survival was 34. However, these differences were not statistically significant ( Figure 3 ). The analysis showed that the hazard ratio-Exp (B) for liver metastases was 1.49 95% CI (1.098-2.022), p=0.01. These factors suggest that the type of liver metastases in patients with colorectal cancer is a significant prognostic factor for survival. Statistical analysis showed that there was a significant difference in survival time depending on the type of liver metastases (p=0.008, p=0.002). Patients with colorectal cancer and metachronous metastases had a significantly longer survival time. The statistical analysis of survival time showed that median survival was lowest in the group with left hemihepatectomy (about 14 months), and the highest in the group with resection of two segments (48 months). Statistical tests confirmed the difference in the length of survival among the types of liver resections as significant (p=0.004, p=0.043), and type of resection in relation to the other factors in terms of survival as non-significant. Extent of resection was also not proved as a significant factor in terms of survival. The number of metastases was proved to be a significant predictor of survival in patients with colorectal cancer metastases of the liver. Patients with 2 to 4 metastases had a 1.5 times higher risk of fatal outcome compared to patients with one metastasis. Patients with more than 4 metastases had a twofold higher risk compared to patients with one metastasis. Statistical tests Log Rank and Breslow confirmed the difference in the length of survival time as significant (p <0.0001).
Patients with bilateral localization of liver metastases survived significantly shorter compared to patients with unilateral localization of metastases. Values of Hgb (p=0.007) and values of the tumor marker CEA (p=0.008) were confirmed as significant predictors. The risk of a fatal outcome was reduced by 11% by increasing the HGB by 1. Increasing tumor marker CEA 1 increased the risk of a fatal outcome by 0.1%.
Discussion
The surgical resection represents the only curative treatment approach in patients with CRLM; in larger series the treated patients with resection have mean 5-year survival rate of 25% to 44% [15, 20, 21] , but only 15-25% [22] of liver metastases are initially resectable. Numerous publications indicate that gender and age do not significantly affect the survival of patients after resection of CRLM [23] [24] [25] . Many authors who compared synchronous with metachronous metastases, found superior results in favor of metachronous metastases [26] [27] [28] [29] , and others showed similar survival rates for both types of CRLM [30, 31] . Tumor size of potentially resectible CRLM has been studied as a prognostic factor with contradictory results [32] . Ercolani et al. [33] demonstrated that the total tumor volume of liver metastases had a stronger impact on the survival compared to the number and location of metastases. In the multifactorial prognostic model described by Rees et al. [34] the number of CRLM>3 represents an independent prognostic factor for low rate of survival. Better survival of patients with four or more metastases was observed by Pawlik et al. [35] , 5-year OS median survival of 50.9%, and Kornprat et al. [36] , 5-year survival of 33% OS. The prognostic significance of bilobar distribution of colorectal metastases became controversial. Some studies indicate the bilobar distribution as a poor prognostic factor, while others are reporting that it does not affect survival [37, 38] . Tomlinson et al. [39] report five and ten percent survival OS of 29% and 25% with bilateral resection. Type of resection of the liver does not affect the survival of patients with CRLM. Non-anatomical resection is inferior compared to the anatomical resection regarding the marginal status, recurrent rate and survival [40] . Our study showed that the type of metastases, localization and inability to radical resection has a statistical significance in terms of survival. The type and extent of liver resection does not affect the survival, but the presence of metastases in the regional lymph glands, extrahepatic distant metastases, the elevated amount of CEA and stage IV disease have also significant effects on survival of patients after liver resection. Fong et al. [41] created a clinical risk score (CRS) using a regressive analysis of multiple clinical factors of patients resected due to colorectal liver metastases. They found five clinical criteria that have prognostic significance for survival: lymph node -initially positive, CEA>200 ng/ml, >1 lesion liver, lesion>5 cm, DFI less than 1 year from the initial resection. They noticed that patients with CRS of 0, 1, 2 have a fondness for survival and surgical resection is a rational therapy. Patients with CRS 3, 4 and 5 have low survival and therefore surgical resection should be planned in the context of chemotherapy.
Conclusion
There are several ways for treatment of patients with colorectal liver metastases: radiofrequent ablation, transarterial chemoembolization, chemo-and radiotherapy as well as in selected cases liver transplantation, but only liver resection has curative sense. The surgical strategy for resection in context of increasing the percent of patients with resectable potential is the only possible factor for long-term survival.
